Actinium Pharmaceuticals, Inc. (ATNM)
1.28
-0.05
(-3.76%)
USD |
NYAM |
Jan 20, 16:00
1.29
+0.01
(+0.78%)
After-Hours: 20:00
Actinium Pharmaceuticals Free Cash Flow: -25.04M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| Altimmune, Inc. | -66.66M |
| Aldeyra Therapeutics, Inc. | -40.08M |
| Avanos Medical, Inc. | 74.90M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.325M |
| Cash from Financing (Quarterly) | -0.209M |
| Free Cash Flow Per Share (Quarterly) | -0.2028 |
| Free Cash Flow to Equity (Quarterly) | -6.178M |
| Free Cash Flow to Firm (Quarterly) | -6.325M |
| Free Cash Flow Yield | -62.71% |